Suspect held as bogus drug kills 4
(Shanghai Daily)
Updated: 2006-05-15 06:43 Inspectors have found serious quality problems at the drugmaker, Cao said,
without elaborating, and police have started an investigation at the company.
A Guangdong Province-based newspaper said yesterday the firm had also made
fake medications besides Armillarisin A.
The firm, based in a Qiqihar suburb, has more than 300 employees.
The state-owned company was restructured into a private business last year.
The scandal was discovered in April when patients in Guangdong Province
developed kidney failure.
The gate of Qiqihar
No. 2 Pharmaceutical Co Ltd where the fake drugs were produced.
[cctv.com] | Between April 22 and 24, two liver
patients at a provincial hospital reported kidney failure.
Then "many more" patients reported similar injuries, authorities said.
Guangdong's liver experts blamed the kidney failures on a bad reaction to the
Armillarisin A injections made by Qiqihar No. 2 Pharmaceutical.
On May 3, Guangdong's FDA and Health Department sealed up all the firm's
Armillarisin A injections at the hospital and banned the product from sale.
On the same day, the Guangdong authorities reported the matter to the state
drug adverse reaction center.
On May 11, the province began banning all medications from the Qiqihar firm.
Heilongjiang authorities have confiscated nearly 1.2 million ampoules of the
Qiqihar drugmaker's injections.
Shanghai hospitals and drug stores said they don't sell the troubled
products.
|
